Dabigatran Following Transient Ischemic Attack and Minor Stroke

NCT02295826 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Transient Ischemic Attack
Minor Ischemic Stroke

Interventions

DRUG: Dabigatran
DRUG: Acetylsalicylic acid

Sponsor

University of Alberta